Log in to save to my catalogue

Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury

Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2405335113

Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury

About this item

Full title

Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Journal of neurotrauma, 2020-10, Vol.37 (19), p.2131-2140

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

Acute lung injury (ALI) and cardiac dysfunction are common in traumatic brain injury (TBI) patients and always indicate poor outcomes. Inflammatory responses play important roles in TBI-induced cardiac and pulmonary damage. Fingolimod, an immunomodulatory agent, alleviates brain edema, restores the integrity of the blood-brain barrier (BBB), and im...

Alternative Titles

Full title

Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2405335113

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2405335113

Other Identifiers

ISSN

0897-7151

E-ISSN

1557-9042

DOI

10.1089/neu.2019.6951

How to access this item